Matrix to set up two JVs in India, Ireland

 The joint venture companies will be engaged in the business of development of finished dosage forms and formulation dossiers, obtaining marketing authorisations, and marketing these dossiers/marketing authorisations to generic pharma companies in Europe.

 While the JV that is being set up in India is named Medikon Galenicals Private Limited, the other JV to be based in Ireland will be called CEM Pharma Life Sciences Limited.

 The investment partners in these two joint venture companies are H Fischer & Co International GmbH and CES Beteiligungs GmbH. Both the companies are part of a $ 300 million German pharmaceutical player with a focus on generics.

 The Indian JV proposes to set up a development centre in Hyderabad to develop finished dosage forms and dossiers.